EP2440183
Bætt lípíðsamsetning
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.6.2010EP published:
18.7.2018EP application number:
10786869.7
EP translation filed:
22.8.2018Grant published:
15.9.2018EPO information:
European Patent Register
Max expiry date:
9.6.2030Expiry date:
9.6.2026Next due date:
30.6.2026
Title:
IMPROVED LIPID FORMULATION
Timeline
Today
10.6.2010EP application
18.7.2018EP Publication
22.8.2018Translation submitted
15.9.2018Registration published
9.6.2026Expires
Owner
Name:
Arbutus Biopharma CorporationAddress:
100- 8900 Glenlyon Parkway, Burnaby, BC V5J 5J8, CA
Inventor
Name:
AKINC, AkinAddress:
Cambridge, MA, US
Name:
DORKIN, Joseph, R.Address:
Cambridge, MA, US
Name:
QIN, XiaojunAddress:
Cambridge, MA, US
Name:
CANTLEY, WilliamAddress:
Cambridge, MA, GB
Name:
MANOHARAN, MuthiahAddress:
Cambridge, MA, US
Name:
RAJEEV, Kallanthottathil, G.Address:
Cambridge, MA, US
Name:
NARAYANANNAIR, Jayaprakash, K.Address:
Cambridge, MA, US
Name:
JAYARAMAN, MuthusamyAddress:
Cambridge, MA, US
Name:
CHEN, JianxinAddress:
Cambridge, MA, US
Name:
ANSELL, StevenAddress:
Cambridge, MA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
185800 PDate:
10.6.2009Country:
US
Number:
244834 PDate:
22.9.2009Country:
US
Classification
Categories:
A61K 9/127, C07C 229/12, A61K 31/221, C12N 15/113, A61K 48/00, A61K 47/14
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 8.5.2019
Expires: 9.6.2020
Payer: Árnason Faktor
Number: 11
Paid: 5.5.2020
Expires: 9.6.2021
Payer: Árnason Faktor ehf.
Number: 12
Paid: 11.5.2021
Expires: 9.6.2022
Payer: Árnason Faktor ehf.
Number: 13
Paid: 6.5.2022
Expires: 9.6.2023
Payer: Árnason Faktor ehf.
Number: 14
Paid: 24.5.2023
Expires: 9.6.2024
Payer: Árnason Faktor ehf.
Number: 15
Paid: 7.5.2024
Expires: 9.6.2025
Payer: Árnason Faktor ehf.
Number: 16
Paid: 22.5.2025
Expires: 9.6.2026
Payer: Árnason Faktor ehf.